Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class III · Low risk Terminated Initiated Feb 25, 2016 (11 years ago)

Telmisartan Tablets

Class III — Low risk. Unlikely to cause harm, but violates FDA regulations.

Why it was recalled

Presence of Foreign Substance: Product complaint for the presence of foreign matter identified as silicone within the tablet.

Cause type: Particulate / foreign matter

Visible foreign particles - glass, metal, fibers or other material - found in the product. Particles can enter from equipment wear, containers or the process, and are dangerous in injectables. All particulate / foreign matter recalls.

What was recalled

Telmisartan Tablets, USP, 80 mg, 30-count (3 x 10 unit-dose blisters) per carton, Rx only, Manufactured by: Torrent Pharmaceuticals LTD., Indrad-382 721, Dist. Mehsana, INDIA.; For: Torrent Pharma Inc., 150 Allen Road, Suite 102, Basking Ridge, NJ 07920, NDC 13668-158-72, UPC 3 13668 158 72 4.

Affected NDC 13668-0158-72

Compare with the code on your package — it is the most precise check available.

Drug: Telmisartan Category: Blood Pressure Medication

Recalling firm
Torrent Pharmaceuticals Limited
NDC code
13668-158-72
Origin
N/A, India
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0824-2016 · FDA notice

Low risk, still worth a check. Class III means the product is unlikely to cause harm but breaks an FDA rule (often labeling). If your lot matches, your pharmacy will normally swap it; there is no need for alarm. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other Telmisartan recalls

See all
Class II · Moderate risk

Telmisartan Tablets

Failed Stability Specifications: Out of specification for blend uniformity.

Terminated Stability / shelf life Micro Labs Limited NDC 42571-227-30 D-0388-2024
Class II · Moderate risk

Telmisartan and Hydrochlorothiazide Tablets USP

Defective Container: Recall of these batches has been initiated due to complaints of difficult to open blister and tablet breaks while opening the blister .

Terminated Packaging defect Glenmark Pharmaceuticals Inc., USA NDC 68462-841-13 D-1306-2022
Class II · Moderate risk

Telmisartan and Hydrochlorothiazide Tablets USP

Defective Container: Recall of these batches has been initiated due to complaints of difficult to open blister and tablet breaks while opening the blister .

Terminated Packaging defect Glenmark Pharmaceuticals Inc., USA NDC 68462-842-13 D-1305-2022

Other particulate / foreign matter recalls from 2016

All particulate / foreign matter recalls
Class III · Low risk

Pentasa (mesalamine)

Presence of Foreign Tablets/Capsules; 500 mg capsules were found in bottles labeled to contain 250 mg capsules

Terminated Particulate / foreign matter Shire PLC NDC 54092-189-81 D-0432-2017
Class II · Moderate risk

Metformin Hydrochloride Tablets

Presence of Foreign Tablets/Capsules; report of Amlodipine Tablets found in 1000 count bottles of Metformin Hydrochloride Tablets USP

Terminated Particulate / foreign matter Ascend Laboratories LLC NDC 67877-217-10 D-0163-2017